Shifting the scales: a promising new era for weight-loss drugs With obesity rates continuing to rise, the need for pharmacological options to help patients safely lose weight is urgent, but there are several promising drugs on the horizon.…
Whole-genome sequencing is ‘feasible’ for screening in primary care, research suggests Presenting their findings, study authors said genomic sequencing in primary care could change the way patients and their families are managed by GPs.…
Pharmacies and opioid dependency: working together to better support recovery One patient in particular led Rachel Britton to discover and develop the role of pharmacists and pharmacy technicians in helping people with opioid dependency.…
Miscarriage: causes, prevention and counselling Guidance on how pharmacists can provide women with practical advice and support during pregnancy and in the event of a miscarriage.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
NHS England to trial inclusion of depression in new medicine service David Webb, chief pharmaceutical officer for England, told the 2022 Clinical Pharmacy Congress that the pilot was "just the tip of the iceberg in terms of opportunity" for pharmacy.…
Antibiotic use in older adults linked to inflammatory bowel disease, research suggests Patients aged 60 years and over who had received five or more courses of antibiotics in five years were 2.3 times more likely to develop inflammatory bowel disease.…
Register of pregnant patients taking acne drug isotretinoin under consideration by NHS Digital NHS Digital clinical lead Paul Brown told delegates at the Clinical Pharmacy Congress that other high-risk medicines are also being considered.…
Premature ovarian insufficiency: diagnosis and management Premature ovarian insufficiency (or failure, as it used to be known) affects around 1% of women aged under 40 years in the UK. Pharmacists should therefore understand its health consequences and be able to advise on the available treatment options.…
GPhC scraps two-year wait for entry to independent prescriber training Registered pharmacists will be able to begin independent prescribing training at any time, provided they have relevant experience and are able to recognise, understand and articulate the skills required by a prescriber.…
